Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491))

Pratibha Pandey; Fahad Khan; Tarun Kumar Upadhyay; Moon Seungjoon; Moon Nyeo Park; Bonglee Kim

doi:10.1016/j.biopha.2023.115388

Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491))

Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, Moon Seungjoon, Moon Nyeo Park, Bonglee Kim

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that the acknowledgements in the original article was incorrect.

Original language	English
Article number	115388
Journal	Biomedicine and Pharmacotherapy
Volume	167
DOIs	https://doi.org/10.1016/j.biopha.2023.115388
Publication status	Published - Nov 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.biopha.2023.115388

Fingerprint

Dive into the research topics of 'Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491))'. Together they form a unique fingerprint.

Cite this

Pandey, P., Khan, F., Upadhyay, T. K., Seungjoon, M., Park, M. N., & Kim, B. (2023). Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491)). Biomedicine and Pharmacotherapy, 167, Article 115388. https://doi.org/10.1016/j.biopha.2023.115388

Pandey, Pratibha ; Khan, Fahad ; Upadhyay, Tarun Kumar et al. / Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491)). In: Biomedicine and Pharmacotherapy. 2023 ; Vol. 167.

@article{a1f1e4e3253e450a810dcdaa76745102,

title = "Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491))",

abstract = "The authors regret that the acknowledgements in the original article was incorrect.",

author = "Pratibha Pandey and Fahad Khan and Upadhyay, {Tarun Kumar} and Moon Seungjoon and Park, {Moon Nyeo} and Bonglee Kim",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = nov,

doi = "10.1016/j.biopha.2023.115388",

language = "English",

volume = "167",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson s.r.l.",

}

Pandey, P, Khan, F, Upadhyay, TK, Seungjoon, M, Park, MN & Kim, B 2023, 'Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491))', Biomedicine and Pharmacotherapy, vol. 167, 115388. https://doi.org/10.1016/j.biopha.2023.115388

Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491)). / Pandey, Pratibha; Khan, Fahad; Upadhyay, Tarun Kumar et al.
In: Biomedicine and Pharmacotherapy, Vol. 167, 115388, 11.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491))

AU - Pandey, Pratibha

AU - Khan, Fahad

AU - Upadhyay, Tarun Kumar

AU - Seungjoon, Moon

AU - Park, Moon Nyeo

AU - Kim, Bonglee

PY - 2023/11

Y1 - 2023/11

N2 - The authors regret that the acknowledgements in the original article was incorrect.

AB - The authors regret that the acknowledgements in the original article was incorrect.

UR - http://www.scopus.com/inward/record.url?scp=85172448111&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2023.115388

DO - 10.1016/j.biopha.2023.115388

M3 - Comment/debate

C2 - 37741799

AN - SCOPUS:85172448111

SN - 0753-3322

VL - 167

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

M1 - 115388

ER -

Pandey P, Khan F, Upadhyay TK, Seungjoon M, Park MN, Kim B. Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491)). Biomedicine and Pharmacotherapy. 2023 Nov;167:115388. doi: 10.1016/j.biopha.2023.115388

Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491] (Biomedicine & Pharmacotherapy (2023) 161, (S0753332223002792), (10.1016/j.biopha.2023.114491))

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this